New pill aims to calm enlarged prostate woes
NCT ID NCT07270432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine, DNN.65.21.005, against a standard drug (Combodart) to see if it safely reduces urinary problems caused by an enlarged prostate. About 218 men aged 50 and older with bothersome symptoms will take the drug for 180 days. The main goal is to measure changes in symptom scores from the start to the end of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC HYPERPLASIA, BENIGN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.